All submission components (cover letter, manuscript text, tables, figures, related papers, etc) must be submitted online via the journal’s submission portal and review system: https://mc.manuscriptcentral.com/oncology
Requirements for all submissions generally should conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals.”
To facilitate our review process, each title page must include the following:
By submitting your manuscript, you hereby guarantee that: 1) all sources used have been cited and listed in the references section; and 2) all necessary permissions have been obtained and credit properly given for content (ie, text and graphical items such as tables and figures) used in whole or part in the manuscript/eAppendix not considered to be original work.
To access a complete version of the ONCOLOGY® guidelines for authors, please visit the following link:
Only persons who have made a direct contribution to the content of a paper should be listed as authors. Group authorship may be used where specified authors assume responsibility for the entire group. In this case, only the specified authors must meet the criteria for
authorship outlined below, and all members of the group may be listed in a footnote but are not acknowledged as authors.
Authorship Form. All authors must read and sign the Journal’s Authorship Form. CancerNetwork/ONCOLOGY® uses the criteria provided by the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” to determine authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on substantial contributions to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or revising it critically for important intellectual content; and on (c) final approval of the version to be published. Conditions (a), (b), and (c) must all be met. All authors are required to read and sign the Journal’s Authorship Form affirming that they have met the criteria for authorship and have agreed to transfer copyright to CancerNetwork/ONCOLOGY®. Individuals who have contributed to a paper but who do not meet the criteria for authorship should be acknowledged.
The form should be included with submission and uploaded directly to Manuscript Central. Forms can also be sent to firstname.lastname@example.org.
Our policy requires all authors disclose relationships with any commercial interest that may present a conflict of interest if: (a) the relationship is financial and occurred within the past 12 months; and (b) the author discusses products or services of that commercial interest. Relevant financial relationships are those relationships in which the author (and/or the author’s spouse or partner) benefits in any dollar amount by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (eg, stocks, stock options, or other ownership interests, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles, such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and/or other activities for which remuneration is received or expected. In addition, authors are required to report all financial and material support for their research, which includes (but is not limited to) grant support and funding sources and any provision of equipment or supplies.
The name of the organization funding or initiating a research project should be made explicit on the title page (eg, “This study was funded by the XYZ Corporation.”). Relevant financial relationships (whether direct to the authors or through a third party) for research and/or writing, including funding, grants, honoraria, etc, must also be named on the title page. If the funding organization had any role in the collection of data, its analysis and interpretation, and/or in the right to approve or disapprove publication of the finished manuscript, this must be noted in the cover letter and described in the Methods section of the text. The editorial staff may inquire further about financial disclosure after the manuscript is submitted. If the manuscript is accepted for publication, disclosure statements will be printed as part of the published paper.
Author Disclosure Form. All authors must read and sign the Journal’s Author Disclosure Form. The form should be included with submission and uploaded directly to Manuscript Central. Forms can also be sent to email@example.com.
Data and/or figures reproduced from another published source must be properly cited and acknowledged. Authors are required to obtain written permission from the appropriate author and/or copyright holder to reproduce previously published or copyrighted material. Authors must also obtain permission from at least 1 author when citing unpublished data, “in-press” articles, and/or personal communications. Copies of permission statements should be submitted with the manuscript.